Abstract to Article: A Publisher’s Perspective on Transforming Abstracts

Event Information

Share this event

Date and Time

Location

Location

Mortimer B. Zuckerman Research Center, entrance on 69th street

Room 105

417 E 68th Street

New York, NY 10065

View Map

Event description
Get insider tips from Elsevier on publishing in "The Lancet" and other journals, plus advice on transforming your abstract to an article.

About this Event

Join our distinguished speakers and discover:

  • The publishing process at The Lancet and key suggestions for effective writing
  • Best practices for preparing/writing an abstract + tips for turning your abstract into a research paper
  • Strategies for long view publication planning
  • Tips for creating graphical abstracts

Speakers

Angela Welch, PhD., Oncology Publisher, Elsevier

Angela Welch is a Senior Publisher of Oncology journals at Elsevier. Angela received her PhD in Biomedical Engineering from Rensselaer Polytechnic Institute in 2010, where she investigated tissue engineering applications in peripheral nerve repair. Upon completion of her doctorate, Angela translated her biomedical background into publishing, where she oversaw the financial and strategic health of a suite of Chemical and Biomedical Engineering journals. In 2018, Angela transitioned to a new portfolio of journals in Oncology and Hematology. Angela has enjoyed traveling around the world and sharing her insights through author, reviewer, and smart-searching workshops.

Rebecca Cooney, PhD., North American Executive Editor, The Lancet

Rebecca Cooney is the North American Executive Editor of The Lancet. Rebecca received her PhD in Psychology from Stanford University in 2007 and subsequently trained as a fellow in Child and Adolescent Psychiatry at Columbia University where she studied the neural basis of mood and anxiety disorders. Prior to joining The Lancet family in 2012, she worked as an associate and assistant editor at The Annals of New York Academy of Sciences. As a representative of The Lancet in the US, Rebecca is particularly interested in liaising with the medical and health communities to provide information on and support for author and reviewer best practices and publication transparency.

Mark M. Souweidane, MD, Pediatric Neurosurgeon, Memorial Sloan Kettering Cancer Center

Dr. Mark M. Souweidane, MD is internationally recognized as a leader in pediatric neurosurgery, with a career focus on CNS tumors of childhood. He is the Vice Chairman of the Department of Neurological Surgery at the Weill Cornell Medical College and director of pediatric neurosurgery at the New York-Presbyterian Hospital/Weill Medical Center and Memorial-Sloan Kettering Cancer Center.

Dr. Souweidane received his bachelors of Science degree from the University of Michigan and his medical doctorate degree from Wayne State University. He completed his neurosurgery training at NYU Medical Center under the mentorship of Dr. Fred Epstein and completed his fellowship in pediatrics at the Hospital for Sick Children in Toronto, Canada. Dr. Souweidane is board-certified by the American Board of Neurological Surgery and the American Board of Pediatric Neurological Surgery. He is a fellow of the American College of Surgeons and the American Academy of Pediatrics.

Dr. Souweidane’s clinical and scholarly contributions have helped define the contemporary fields of minimally invasive endoscopic surgery and direct drug delivery for brain tumors. He directs a translational laboratory focusing on novel drug delivery techniques for childhood brain tumors. He is the principal investigator (PI) for a clinical trial using convection-enhanced delivery (CED) and immuno-radiotherapy as a novel therapeutic approach for children with DIPG (NCT01502917). In 2017 Dr. Souweidane was selected by the National Cancer Institute (NCI) to serve as the Neurological Surgery Special Expert on its Brain Malignancies Steering Committee (BMSC) and was appointed to the Children’s Oncology Group (COG) CNS Steering Committee. He is the past chair of the editorial board for Journal of Neurosurgery Pediatrics.

Steven M. Horwitz, MD, Medical Oncologist, Memorial Sloan Kettering Cancer Center.

Dr. Steven Horwitz, MD is an Associate Attending in the Department of Medicine at Memorial Sloan Kettering Cancer Center in New York City. He earned his medical degree at Case Western Reserve University School of Medicine, completed an internship and residency in internal medicine at the University of Rochester/Strong Memorial Hospital, and then completed a fellowship in medical oncology at Stanford University Medical Center.

Much of his current research is dedicated to investigating targeted or immunotherapeutic approaches to try to identify better, and often less toxic treatments for individuals with T-cell lymphomas. His research also focuses on better understanding mechanisms of response and resistance to novel drugs in T-cell lymphoma to help provide individualized treatments in the future.

Dr. Horwitz participates in several national, and international committees and consortiums dedicated to the understanding and advancement of treatment for T-cell lymphoma. Since 2017 he has been the Chair of the NCCN panel on Guidelines for Treatment of T-Cell/Primary Cutaneous B-Cell Lymphomas.

____________________________________________________________________________________

"Abstract to Article" is an MSKCC Library Advancing Authorship event.

Date and Time

Location

Mortimer B. Zuckerman Research Center, entrance on 69th street

Room 105

417 E 68th Street

New York, NY 10065

View Map

Save This Event

Event Saved